geographic atrophy

Read more about the article EyeWorld Weekly, April 18, 2025
EyeWorld Weekly

EyeWorld Weekly, April 18, 2025

➤ Positive results in Phase 1 trial for geographic atrophy cell-based therapy ➤ Enrollment complete for Phase 3 DME drop trials ➤ Enrollment complete in study for hydrogel retinal sealant ➤ First patient dosed in Phase 2 trial studying oral diabetic retinopathy therapy ➤ Regenerative Medicine Advanced Therapy designation granted to gene therapy candidate for X-linked retinoschisis ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, April 18, 2025
April 18, 2025
Read more about the article EyeWorld Weekly, February 28, 2025
EyeWorld Weekly

EyeWorld Weekly, February 28, 2025

➤ ASCRS EyeWorld Weekly: View the current issue ➤ Transepithelial crosslinking NDA submission accepted ➤ Fast Track designation granted to drop being investigated for night driving impairment due to visual disturbances ➤ First-in-human interventional study for gene therapy treating Leber congenital amaurosis 4 ➤ Positive outcomes observed for geographic atrophy drug ➤ Regenerative Medicine Advanced Therapy designation granted to stem cell therapy for dry AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 28, 2025
February 28, 2025